To explore the potential applications of Artificial Intelligence (AI) in the management of epilepsy, particularly in treatment strategies for drug-resistant epilepsy (DRE), EEG analysis, and surgical interventions, emphasizing the significance of AI in improving patient outcomes.
Key Findings:
AI algorithms can significantly enhance EEG interpretation, achieving near-perfect accuracy in controlled datasets, with implications for clinical practice.
AI models have shown superior specificity and comparable sensitivity to human experts in multicenter evaluations, highlighting their potential impact on diagnostic processes.
Machine learning can improve surgical planning and outcome prediction for epilepsy surgeries, with accuracy rates exceeding traditional methods, suggesting a shift in surgical decision-making.
Interpretation:
AI has the potential to transform epilepsy management by providing tools that enhance diagnostic accuracy and surgical decision-making, though many applications require further validation and regulatory oversight to ensure safety and efficacy.
Limitations:
Current AI applications are primarily validated on controlled datasets, necessitating broader clinical validation, particularly in diverse patient populations.
Many AI technologies remain in the investigational phase and are not yet ready for routine clinical use, highlighting the need for ongoing research.
Conclusion:
AI should be integrated as a complementary tool in epilepsy management, enhancing clinician capabilities rather than replacing them, with a focus on collaborative decision-making.
